IRB Barcelona BioMed Conferences
Cancer is the second leading cause of death worldwide, and a problem that escalates in an aging population. Although significant progress has been made in understanding the genetic and epigenetic determinants of cancer, little attention has been paid to post-transcriptional regulation of gene expression. The process of mRNA translation shapes the proteome and plays an essential role in the reprogramming of cancerous cells, holding the promise of novel anti-cancerous therapies. This conference will bring together basic experts working at the interphase of translation, cancer progression and microenvironment interactions, including basic research on post-transcriptional mechanisms, animal models and novel technologies, with the aim to provide a stimulating environment and illuminate discovery in this innovative field.
More information and registration
